Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Chemours (CC) Equity Income (2016 - 2025)

Chemours (CC) has 12 years of Equity Income data on record, last reported at $9.0 million in Q4 2025.

  • For Q4 2025, Equity Income changed 0.0% year-over-year to $9.0 million; the TTM value through Dec 2025 reached $35.0 million, down 20.45%, while the annual FY2025 figure was $35.0 million, 18.6% down from the prior year.
  • Equity Income reached $9.0 million in Q4 2025 per CC's latest filing, roughly flat from $9.0 million in the prior quarter.
  • Across five years, Equity Income topped out at $16.0 million in Q2 2022 and bottomed at $7.0 million in Q4 2023.
  • Average Equity Income over 5 years is $11.1 million, with a median of $11.0 million recorded in 2021.
  • Peak YoY movement for Equity Income: surged 200.0% in 2021, then plummeted 41.67% in 2023.
  • A 5-year view of Equity Income shows it stood at $11.0 million in 2021, then rose by 9.09% to $12.0 million in 2022, then plummeted by 41.67% to $7.0 million in 2023, then increased by 28.57% to $9.0 million in 2024, then changed by 0.0% to $9.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Equity Income were $9.0 million in Q4 2025, $9.0 million in Q3 2025, and $9.0 million in Q2 2025.